RedHill Biopharma (RDHL) Current Assets (2012 - 2025)
RedHill Biopharma (RDHL) posted Current Assets of $6.53 million for the quarter ended Dec 31, 2025, down 45.2% from $11.91 million a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Current Assets (2012 - 2025) Analysis & Trends
Since the quarter ended Dec 31, 2012, RedHill Biopharma has reported Current Assets for 25 quarters.
- Annual Current Assets has declined for four consecutive years, with a five-year compound annual growth rate of -37.9% (years ended Dec 2020 to Dec 2025).
- In prior years, RedHill Biopharma's Current Assets was $11.91 million in the year ended Dec 31, 2024 (-26.2%), $16.14 million in the year ended Dec 31, 2023 (-81.2%), $85.9 million in the year ended Dec 31, 2022 (-3.6%) and $89.15 million in the year ended Dec 31, 2021 (+26.5%).
- The figure for the quarter ended Dec 31, 2025 stands as the lowest quarterly Current Assets in data going back to the quarter ended Dec 31, 2012.
- The strongest year-over-year quarter for Current Assets in the past five years was the quarter ended Jun 30, 2021, with growth of 61.1%; the weakest was the quarter ended Dec 31, 2023, with a decline of 81.2%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | RedHill Biopharma | 7.53 Mn | 7.53 Mn | - | 6.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 6.53 Mn |
| Jun 30, 2025 | 12.56 Mn |
| Dec 31, 2024 | 11.91 Mn |
| Jun 30, 2024 | 15.70 Mn |
| Dec 31, 2023 | 16.14 Mn |
| Jun 30, 2023 | 27.05 Mn |
| Dec 31, 2022 | 85.90 Mn |
| Jun 30, 2022 | 91.27 Mn |
| Dec 31, 2021 | 89.15 Mn |
| Jun 30, 2021 | 98.49 Mn |
| Dec 31, 2020 | 70.50 Mn |
| Jun 30, 2020 | 61.13 Mn |
| Dec 31, 2019 | 53.21 Mn |
| Jun 30, 2019 | 39.97 Mn |
| Dec 31, 2018 | 56.79 Mn |
| Jun 30, 2018 | 32.22 Mn |
| Mar 31, 2018 | 40.74 Mn |
| Dec 31, 2017 | 51.68 Mn |
| Dec 31, 2016 | 67.82 Mn |
| Mar 31, 2015 | 34.90 Mn |
API Access
RedHill Biopharma Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();